Dr. Huhn is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2020 W Harrison St
Chicago, IL 60612Phone+1 312-572-4575Fax+1 312-572-4502
Education & Training
Rush University Medical CenterFellowship, Infectious Disease, 2004 - 2005
Duke University HospitalResidency, Internal Medicine, 1996 - 1999
Tulane University School of MedicineClass of 1996
Certifications & Licensure
IL State Medical License 2003 - 2026
NC State Medical License 1997 - 2005- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Study on Immunopathogenesis in HIV and Hepatitis C Coinfection Start of enrollment: 2011 Jul 01
- DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects Start of enrollment: 2012 Jan 01
- Lubiprostone as a Modulator of Gut Microbial Translocation in HIV With Incomplete CD4 Recovery on Antiretroviral Therapy Start of enrollment: 2013 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 915 citationsThe major genetic determinants of HIV-1 control affect HLA class I peptide presentationFlorencia Pereyra, Xiaoming Jia, Paul J. McLaren, Amalio Telenti, de Bakker Pi
Science. 2010-12-10 - 239 citationsSwitching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised...Anthony Mills, Jose R. Arribas, Jaime Andrade-Villanueva, Giovanni DiPerri, Jan van Lunzen
The Lancet. Infectious Diseases. 2016-01-01 - 23 citationsNephrotoxicity Associated with Concomitant Use of Ledipasvir‐Sofosbuvir and Tenofovir in a Patient with Hepatitis C Virus and Human Immunodeficiency Virus CoinfectionKristen L. Bunnell, Sonia Vibhakar, Robert C. Glowacki, Maureen Gallagher, Albert M. Osei
Pharmacotherapy. 2016-09-01
Journal Articles
- Effect of Bamlanivimab as Monotherapy or in Combination with Etesevimab on Viral Load in Patients with Mild to Moderate COVID-19Barry Heller, Gregory Huhn, Valentina Stosor, Imad Shawa, JAMA
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19Robert L Gottlieb, Joseph Boscia, Gregory Huhn, Valentina Stosor, Imad Shawa, The New England Journal of Medicine
- SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19Robert L Gottlieb, Joseph Boscia, Gregory Huhn, Valentina Stosor, Imad Shawa, The New England Journal of Medicine
- Join now to see all
Authored Content
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19August 2020
- Join now to see all
Press Mentions
As New COVID Variants Emerge at a Faster Pace, Here's What You Need to KnowOctober 29th, 2022- New COVID Variants Emerging ‘More Quickly' Now. Here's What That SignalsOctober 28th, 2022
- Illinois Seeing ‘Uptick' in COVID Cases, Health Department SaysOctober 28th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
